We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Faulty Gene Causes Myotonic Dystrophy

By Biotechdaily staff writers
Posted on 05 Aug 2002
Researchers have found that in myotonic dystrophy (DM), the most common form of muscular dystrophy in adults, a faulty gene creates flawed mRNA that results in the loss of chloride channel protein (ClC-1) from the surface membrane of the main chloride channel in muscle, which causes degeneration and repetitive action potentials (myotonia). The findings were reported in the July 18, 2002, issue of Molecular Cell.

The investigators, from the University of Rochester Medical Center (New York, USA; www.rochester.edu), worked with a transgenic mouse model that mimics human DM. They found that faulty messenger RNA accumulates in the nuclei of cells in muscles from these animals. "Somehow the abnormal mRNA coming from the myotonic dystrophy gene builds up in the nucleus and prevents other RNAs from being spliced correctly. That is what causes this electrical misbehavior in patients with myotonic dystrophy,” said Dr. Charles Thornton, the neurologist who headed the research team.

The faulty mRNA inhibits the manufacture of the chloride channel protein (ClC-1), which is vital for maintaining the proper flow of electricity in muscles. Without the chloride channel, electrical signals in muscles stay "on” for too long, and muscle control becomes unstable.

Dr. Thornton said, "We believe this is the first example of an abnormal gene that has a harmful effect in the human body because the RNA that the gene produces is toxic. Bad RNA is the culprit and good RNA is the victim.”



Related Links:
University of Rochester Medical Center

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Clinical Informatics Platform
CLARION™
New
Hematology Consumables
Bioblood Devices

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
05 Aug 2002  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
05 Aug 2002  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
05 Aug 2002  |   BioResearch